Previous Article | Next Article ![]()
Infection and Immunity, March 2006, p. 1954-1957, Vol. 74, No. 3
0019-9567/06/$08.00+0 doi:10.1128/IAI.74.3.1954-1957.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
and
Michael Glogauer
CIHR Group in Matrix Dynamics and Dental Research Institute, Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada
Received 2 September 2005/ Returned for modification 11 October 2005/ Accepted 27 November 2005
|
|
|---|
|
|
|---|
Enriched native Msp from the T. denticola type strain, ATCC 35405 (4), was prepared as previously described (7, 13). An anti-Msp rabbit antiserum was raised against the Msp complex of the prominent
190-kDa band that had been excised following preparative polyacrylamide gel electrophoresis of unheated samples and then electroeluted at 4°C for 24 h inside dialysis tubing with a 12,000- to 14,000-molecular-weight cutoff (Spectra/Por), followed by overnight dialysis in 10 mM Tris-HCl, pH 8.0.
The PMNs from 10 ml of blood from healthy volunteers were isolated using one-step Polymorphprep (Accurate Chemical, Westbury, NY) (9) and were used, within 3 h, in suspensions of 106 cells/ml of Hanks' balanced salt solution (HBSS). PMNs in the experimental groups were incubated with enriched Msp in HBSS (final concentration range, 0.0064 to 64 µg/ml) for 30 min at room temperature in a shaking bath. Control cells were exposed to the same volume of Msp-free HBSS. The PMNs were washed twice and then subjected to various functional assays in triplicate. At least three independent experiments were performed with cells from different donors. Comparisons of mean values were analyzed by the two-tailed Student t test. Multiple samples were compared by single-factor analysis of variance.
The chemotactic response of PMNs to 106 M formyl-methionyl-leucyl-phenylalanine (fMLP) was assayed for 10 min of incubation at 37°C in a modified Boyden chamber (Transwell; pore size, 3.0 µm; Corning, Inc., Corning, NY) by counting the number of PMNs in 10 microscopic fields (magnification, x40) (24). Pretreatment with Msp diminished the migratory response of these PMNs in a concentration-dependent manner (P < 0.05) (Fig. 1). The chemotaxis experiments were repeated using the highest concentration of Msp (64 µg/ml) which had been heated at 60°C for 30 min or which had been incubated with anti-Msp antibodies or preimmune serum for 1 h at 4°C, followed by absorption by protein A-Sepharose beads (15, 27). Both heating and absorption with anti-Msp antibodies reversed the inhibitory effect (Fig. 1B), indicating that Msp rather than a minor protein or heat-stable contaminant, such as a glycolipid, was the predominant bioactive ingredient. These findings with human PMNs extend a previous observation that Msp (20 µg/ml) impaired chemotaxis of murine PMNs in a Zigmond chamber, in which PMNs migrate laterally from central coordinates on a slide (1).
![]() View larger version (15K): [in a new window] |
FIG. 1. (A) Effect of Msp on neutrophil chemotaxis, assayed using the Boyden chamber with 1 µM fMLP as the chemoattractant. Data are expressed as mean percentages of the control level (taken as 100%) ± standard errors (n = 3). *, P < 0.05. (B) The highest concentration of Msp (64.0 µg/ml) was pretreated with preimmune serum, anti-Msp antiserum, or heat at 60°C for 30 min, and the effect on chemotaxis was compared with that of Msp and Msp-free vehicle (control). Data are expressed as mean percentages of the control level (taken as 100%) ± standard errors (n = 3). *, P < 0.05. Note that the antiserum and 60°C samples were not significantly different from control activated samples but were statistically different from Msp-treated samples. This confirms that the observed effect is a result of the Msp and not a contaminating factor in the bacterial preparation.
|
![]() View larger version (10K): [in a new window] |
FIG. 2. Effect of Msp on neutrophil phagocytosis of IgG-coated FluoSphere polystyrene beads. Results were quantified by fluorescence microscopy and are expressed as the mean number of phagocytosing cells x 100/total counted cells (n = 3). *, P < 0.05. Error bars, standard errors.
|
![]() View larger version (10K): [in a new window] |
FIG. 3. Effect of Msp on neutrophil actin filament assembly assayed by pyrene actin incorporation. Fluorescence intensity was monitored spectrophotometrically in free barbed ends of actin filaments in Msp-pretreated cells exposed to fMLP and was compared to the fluorescence intensity for control cells that were treated with an Msp-free vehicle and were not stimulated with fMLP. Data are expressed as the mean fluorescence intensity relative to control values ± standard errors (n = 3). *, P < 0.05.
|
![]() View larger version (10K): [in a new window] |
FIG. 4. Effect of Msp on fMLP-induced intracellular cytosolic calcium levels. PMNs were loaded with Fluo-3 and allowed to attach for 60 min; then the calcium flux in the cytosol in response to stimulation with 10 nM fMLP was monitored using confocal microscopy. Values are mean amplitudes of calcium transients ± standard errors (n = 3). *, P < 0.05.
|
Apoptosis was measured with the Guava Nexin kit according to its manufacturer's protocol (Guava Technologies Inc., Hayward, CA), using camptothecin (CPT) as a positive control (11). The PMNs (105/test) were incubated with either 64 µg/ml Msp, a control vehicle, or 10 µM CPT (Sigma) for 1, 2, and 3 h. The cells were stained with phycoerythrin-conjugated annexin V, a marker of the early apoptotic pathway, and Nexin 7-amino-actinomycin D, a cell permeant of late-stage apoptosis (16, 25). The cells were analyzed with a Guava personal cytometer. Msp did not induce apoptosis in PMNs compared with vehicle-treated cells, whereas CPT-treated PMNs experienced more-frequent apoptotic events (frequency of apoptosis, 2% ± 0.5% for vehicle-treated PMNs, 4% ± 2.1% for Msp-treated PMNs, and 18% ± 5.3% for CPT-treated PMNs [P < 0.01]). PMNs treated with Msp also showed a lower 7-amino-actinomycin D uptake than PMNs incubated with CPT (2.6% ± 0.7% for vehicle-treated PMNs, 3.8% ± 2.1% for Msp-treated PMNs, and 19.5% ± 4.9% for CPT-treated PMNs [P < 0.01]). These data indicate that Msp induces neither apoptosis nor long-lasting cell membrane permeability in human PMNs.
One of the key functions of cells in innate immunity is their rapid migration (12). Msp impaired human neutrophil chemotaxis and phagocytosis in vitro, probably by perturbing de novo assembly of actin filaments. Calcium is integral to actin filament turnover, which drives membrane lamellipodial extension and resultant locomotion (10). Pretreatment of PMNs with Msp diminished both the cytosolic Ca2+ transient and the detection of actin nucleation sites following exposure of cells to fMLP. These key outcomes impacting the cytoskeleton help explain how Msp may inhibit PMN chemotaxis, perhaps through its impact on cytokinesis. The findings are consistent with previous reports that Msp pretreatment of fibroblasts leads to actin reorganization, diminished calcium store release, and delayed migration (1, 27).
Pretreatment of PMNs with low concentrations of Msp also diminished their capacity to phagocytose IgG-coated microspheres. Inhibition of actin monomer incorporation into filaments would be expected to impair pseudopod formation. Alternatively, Msp could have affected receptor-mediated immunoglobulin engagement analogously to its reduction of the anticipated affinity modulation when the ß1 integrins of fibroblasts engage collagen (15). Msp pretreatment did not affect the agonist-stimulated oxidative response. Others have reported that early-growth-phase culture supernatants, phenol extracts, and some lipoproteins of T. denticola can inhibit oxidative responses in PMNs (18, 19). Our results do not conflict with these reports, since the Msp-containing outer sheath does not shed much when T. denticola is growing in fresh medium, and Msp is a nonacylated protein. Notably, human PMNs are able to phagocytose T. denticola and other oral spirochetes. Yet most strains stimulate the oxidative burst only in the presence of serum, and once they are phagocytosed, failure to stimulate the release of lysosomal enzymes is atypical (3). Our findings suggest that Msp is an unlikely source of these inhibitory activities.
Similarly, Msp did not induce significant apoptosis. This finding is consistent with studies of Msp-treated fibroblasts (15, 27) and T. denticola-treated KB epithelial cells (6), target cells that undergo gross cytoskeletal reorganization but remain viable. Enriched Msp is also known to depolarize HeLa cell membranes, presumably by establishing short-lived ion channels (13). Yet the PMNs in this study did not show signs of significant plasma membrane permeability. Consequently, we conclude that native Msp of T. denticola has selective inhibitory effects on actin-dependent functions of human neutrophils in vitro.
We thank D. A. Grove for technical assistance.
M.G. and R.P.E. are both principal authors. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»